Donor lymphocyte infusions: the long and winding road: how should it be traveled?

Bone Marrow Transplantation
M Tomblyn, H M Lazarus

Abstract

Donor lymphocyte infusions (DLI) often are used after allo-SCT to augment the graft-versus-tumor effect. Timing of infusion varies according to indication, for example to treat tumor recurrence, as a planned strategy to prevent disease relapse in the setting of T-cell-depleted grafts or non-myeloablative conditioning regimens, or as a method to convert mixed to full donor chimerism. The optimal strategy of timing, use of cytotoxic conditioning, cell dose and cell product composition, and so on, for DLI administration remains unclear. Despite varied techniques, DLI may lead to 3-year disease-free survivals (DFS) in excess of 60% for all CML patients and approach 90% in patients with only molecular or cytogenetic relapse. Other hematologic malignancies appear much less responsive, as less than 50% of patients respond and provide, at best, 3-year DFS rates of 20-50%. Multiple myeloma patients have overall response rates of 40-45% after DLI, suggesting benefit in relapsed disease, but limited experiences for diseases such as Hodgkin's lymphoma, myelodysplasia and ALL preclude recommendations for use of DLI at this time. Regardless of the indication, treatment-related mortality after DLI is 5-20% and more than one-third of patients ...Continue Reading

References

Feb 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R H CollinsJ Nemunaitis
Jan 10, 2001·Bone Marrow Transplantation·M SalamaR H Collins
Jan 5, 2002·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·A ShimoniS Giralt
Mar 26, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Karl S PeggsStephen Mackinnon
Apr 30, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Karl S PeggsKwee Yong
Jan 13, 2004·Bone Marrow Transplantation·S DepilUNKNOWN Société Française de Greffe de Moelle et Thérapie cellulaire
Mar 3, 2004·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Elena G ChioreanJeffrey S Miller
Mar 3, 2004·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Eduardus F M PosthumaJ H Frederik Falkenburg
Apr 1, 2005·Leukemia·A YoshimiUNKNOWN European Working Group of MDS in Childhood (EWOG-MDS)
Mar 21, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Carol Ann HuffRichard J Jones
Dec 13, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·R OrM Y Shapira
Dec 13, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Aldemar MonteroA John Barrett
Apr 24, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Bronwen E ShawNigel H Russell

❮ Previous
Next ❯

Citations

Apr 29, 2010·Current Hematologic Malignancy Reports·Alan S Wayne
Jul 6, 2010·Current Oncology Reports·Junya KandaDavid A Rizzieri
Dec 17, 2008·Bone Marrow Transplantation·G CookD I Marks
May 27, 2009·Current Opinion in Hematology·Lisa M ArfonsHillard M Lazarus
Dec 3, 2009·Current Opinion in Pediatrics·Alan S WayneCrystal L Mackall
Jul 20, 2010·Immunotherapy·Anna-Maria GeorgoudakiEvren Alici
Mar 20, 2014·Current Hematologic Malignancy Reports·Amir T Fathi, Yi-Bin Chen
Jul 27, 2011·Expert Review of Clinical Immunology·Aleksandra Petrovic, Gregory Hale
Jan 29, 2014·Seminars in Hematology·Mehdi HamadaniMohamed A Kharfan-Dabaja
Jan 25, 2012·Experimental Hematology·Wichai ChinratanalabBipin N Savani
Nov 19, 2011·Hematology/oncology Clinics of North America·Oana Paun, Hillard M Lazarus
Sep 23, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Lucia FarinaPaolo Corradini
Apr 5, 2014·Transfusion·James A HutchinsonEdward K Geissler
Aug 9, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Maria LigaAlexandros Spyridonidis
Jan 8, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Ashley Rosko, Marcos de Lima
Dec 10, 2014·Clinical Lymphoma, Myeloma & Leukemia·Jessica HochbergMitchell S Cairo
Mar 6, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Michael R BishopSergio Giralt
Oct 19, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Amir A ToorMasoud H Manjili
Jul 20, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Evgeny KlyuchnikovNicolaus Kröger
Dec 17, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Matthew P WrightDonna L Forrest
Mar 29, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Yong-Xian HuHe Huang
Oct 28, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Marcel R M van den BrinkMichael R Bishop
Oct 14, 2014·Bone Marrow Transplantation·A GhisoA Bacigalupo
May 25, 2016·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Luca CastagnaLucio Morabito
Apr 30, 2014·Bone Marrow Transplantation·Y ZengE Katsanis
Aug 3, 2017·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Rumi IshiiKazunari Tanabe
Oct 24, 2013·British Journal of Cancer·U ThielUNKNOWN Solid Tumour Working Party and the Paediatric Disease Working Party of the European Group for Blood and Marrow Transplantati
Feb 6, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ming ShiSusumu Ikehara
Jan 14, 2010·Current Opinion in Pediatrics

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
Jeane Hester
Best Practice & Research. Clinical Haematology
Noelle V Frey, David L Porter
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Adrian BloorStephen Mackinnon
© 2022 Meta ULC. All rights reserved